Cargando…
Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy?
Type 1 diabetes (T1D) arises from a failure to maintain tolerance to specific β-cell antigens. Antigen-specific immunotherapy (ASIT) aims to reestablish immune tolerance through the supply of pertinent antigens to specific cell types or environments that are suitable for eliciting tolerogenic respon...
Autores principales: | Creusot, Rémi J., Postigo-Fernandez, Jorge, Teteloshvili, Nato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054431/ https://www.ncbi.nlm.nih.gov/pubmed/30030289 http://dx.doi.org/10.2337/db17-1564 |
Ejemplares similares
-
Optimization of tamoxifen-induced Cre activity and its effect on immune cell populations
por: Donocoff, Rachel S., et al.
Publicado: (2020) -
Preclinical evaluation of a precision medicine approach to DNA vaccination in type 1 diabetes
por: Postigo-Fernandez, Jorge, et al.
Publicado: (2022) -
Humanized Mice Reveal New Insights Into the Thymic Selection of Human Autoreactive CD8(+) T Cells
por: Li, Yang, et al.
Publicado: (2019) -
Manipulating antigen presentation for antigen-specific immunotherapy of autoimmune diseases
por: Streeter, Heather B, et al.
Publicado: (2021) -
Antigen-specific immunotherapy to restore antigen-specific tolerance in Type 1 diabetes and Graves’ disease
por: Zala, Aakansha, et al.
Publicado: (2022)